Lycopene Following Aneurysmal Subarachnoid Haemorrhage
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.
Also called NCT00905931
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 124 participants
- Sponsor
- Registry
-
NCT00905931
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT00905931. Randomized; quadruple masking; primary purpose prevention. Start 2010-09 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Lycopene Following Aneurysmal Subarachnoid Haemorrhage
- Acronym
- LASH
- Condition
- Subarachnoid Hemorrhage
- Condition
- Aneurysm
- Intervention (Drug)
- Lycopene
- Intervention (Drug)
- placebo
- Lead sponsor
- University of Cambridge
- Collaborator
- Cambridge Theranostics Ltd
Record details
- Record id
cardio:ct-nct00905931- Content hash
aa21708979a2a6d686a6be1320734b51010e346f8e565e7381b5715fdd8ba73b